Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis.
Yoneda M, Fujita K, Imajo K, Mawatari H, Kirikoshi H, Saito S, Nakajima A. Yoneda M, et al. Among authors: mawatari h. J Gastroenterol. 2011 Mar;46(3):415-6; author reply 417. doi: 10.1007/s00535-010-0356-8. Epub 2010 Dec 22. J Gastroenterol. 2011. PMID: 21181211 No abstract available.
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. Among authors: mawatari h. J Gastroenterol. 2007 May;42(5):375-81. doi: 10.1007/s00535-007-2014-3. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530362
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. Among authors: mawatari h. J Gastroenterol. 2007 Jul;42(7):573-82. doi: 10.1007/s00535-007-2060-x. Epub 2007 Jul 25. J Gastroenterol. 2007. PMID: 17653654
Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).
Yoneda M, Uchiyama T, Kato S, Endo H, Fujita K, Yoneda K, Mawatari H, Iida H, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Kobayashi N, Kubota K, Saito S, Maeyama S, Sagara M, Aburatani H, Kodama T, Nakajima A. Yoneda M, et al. Among authors: mawatari h. BMC Gastroenterol. 2008 Nov 14;8:53. doi: 10.1186/1471-230X-8-53. BMC Gastroenterol. 2008. PMID: 19014569 Free PMC article.
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, Kato S, Mawatari H, Shibata W, Kitani H, Ikejima K, Kirikoshi H, Nakajima N, Saito S, Maeyama S, Watanabe S, Wada K, Nakajima A. Imajo K, et al. Among authors: mawatari h. Cell Metab. 2012 Jul 3;16(1):44-54. doi: 10.1016/j.cmet.2012.05.012. Cell Metab. 2012. PMID: 22768838 Free article.
LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
Imajo K, Hyogo H, Yoneda M, Honda Y, Kessoku T, Tomeno W, Ogawa Y, Taguri M, Mawatari H, Nozaki Y, Fujita K, Kirikoshi H, Saito S, Sumida Y, Ono M, Wada K, Nakajima A, Eguchi Y. Imajo K, et al. Among authors: mawatari h. PLoS One. 2014 Dec 26;9(12):e115403. doi: 10.1371/journal.pone.0115403. eCollection 2014. PLoS One. 2014. PMID: 25541989 Free PMC article. Clinical Trial.
89 results